SCHEMBL9684858

SCHEMBL9684858

O=[N+]([O-])c1ccoc1[N+](=O)[O-]

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 7/20 0.39
TSHR P16473 3/20 0.39
GPR35 Q9HC97 1/20 0.38
LMNA P02545 2/20 0.38
HSD17B10 Q99714 1/20 0.37
CYP3A4 P08684 2/20 0.35
MAPT P10636 2/20 0.35
KDM4E B2RXH2 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PAX8 Q06710 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
ALDH1A1 P00352 2/20 0.34
MAPK1 P28482 1/20 0.34
POLB P06746 1/20 0.34
ALOX15 P16050 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2059980 0.76
SCHEMBL6168611 0.74
SCHEMBL3698668 0.74
SCHEMBL6461409 0.74
SCHEMBL6168612 0.74
SCHEMBL5492471 0.74
SCHEMBL826470 0.74
SCHEMBL10619998 0.74
SCHEMBL27485700 0.74
SCHEMBL6471705 0.73 LMNA (0.39) TDP1TSHRGPR35LMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-206788185-U A kind of Furaxone metabolite rapid detection card 苏州快捷康生物技术有限公司 2017-12-22 CN claimed
JP-2025477-A None JP disclosed
CN-117686480-B Preparation method and application of high-performance flexible surface-enhanced Raman substrate 深圳北理莫斯科大学 2024-10-01 CN disclosed
CN-117686480-A Preparation method and application of high-performance flexible surface-enhanced Raman substrate 深圳北理莫斯科大学 2024-03-12 CN disclosed
CN-108866010-B One plant of anti-furans benzene olefin(e) acid sodium monoclonal antibody hybridoma cell strain and its application 江南大学 2019-10-01 CN disclosed
US-10364210-B2 Diamine compounds, dinitro compounds and other compounds, and methods of producing thereof and uses related thereof MICROMIDAS, INC. (US) 2019-07-30 US disclosed
CN-108866010-A One plant of anti-furans benzene olefin(e) acid sodium monoclonal antibody hybridoma cell strain and its application 江南大学 2018-11-23 CN disclosed
US-20170275236-A1 DIAMINE COMPOUNDS, DINITRO COMPOUNDS AND OTHER COMPOUNDS, AND METHODS OF PRODUCING THEREOF AND USES RELATED THEREOF MICROMIDAS, INC. (US) 2017-09-28 US disclosed
CN-107208042-A Fusion proteins, recombinant bacteria and methods of using recombinant bacteria 斯波根生物技术公司 2017-09-26 CN disclosed
EP-3186236-A1 DIAMINE COMPOUNDS, DINITRO COMPOUNDS AND OTHER COMPOUNDS, AND METHODS OF PRODUCING THEREOF AND USES RELATED THEREOF Micromidas, Inc. (US) 2017-07-05 EP disclosed
CN-106795127-A Diamine compound, dinitro compound and other compounds and preparation method thereof and relative purposes 微麦德斯公司 2017-05-31 CN disclosed
CN-105961924-A Preparation method of microorganism feed additive, product and application of microorganism feed additive 上海亨康生物科技有限公司 2016-09-28 CN disclosed
WO-2016033348-A1 DIAMINE COMPOUNDS, DINITRO COMPOUNDS AND OTHER COMPOUNDS, AND METHODS OF PRODUCING THEREOF AND USES RELATED THEREOF MICROMIDAS, INC. (US) 2016-03-03 WO disclosed
US-5145975-A Parasiticides THE ROCKEFELLER UNIVERSITY (US) 1992-09-08 US disclosed
US-4942170-A PARASITICIDES, ANTIPROTOZOA AGENTS THE ROCKEFELLER UNIVERSITY (US) 1990-07-17 US disclosed
EP-0355279-A2 Use of nitrogen-containing compounds as antiparasitics, and compositions containing them DRUG & VACCINE DEVELOPMENT CORPORATION (US) 1990-02-28 EP disclosed
JP-H0225477-A AROMATIC DIAMINE COMPOUND AND ITS PRODUCTION IMAI YOSHIO 1990-01-26 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170275236-A1 DIAMINE COMPOUNDS, DINITRO COMPOUNDS AND OTHER COMPOUNDS, AND METHODS OF PRODUCING THEREOF AND USES RELATED THEREOF DDC, DDT, DAO TDP1 1513/4885TSHR 4772/4885GPR35 2961/4885
US-10364210-B2 Diamine compounds, dinitro compounds and other compounds, and methods of producing thereof and uses related thereof DDC, DDT, DAO TDP1 1513/4885TSHR 4772/4885GPR35 2961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.